Abstract
Although since 1998 more than 1,200 different hESC lines have been established worldwide, there is still a recognized interest in the establishment of new lines of hESC, particularly from HLA types and ethnic groups underrepresented among the currently available lines. The methodology of hESC derivation has evolved significantly since the initial derivations using human LIF (hLIF) for maintenance of pluripotency. However, there are still a number of alternative strategies for the different steps involved in establishing a new line of hESC. We have analyzed the different strategies/parameters used between 1998 and 2010 for the derivation of the 375 hESC lines able to form teratomas in immunocompromised mice deposited in two international stem cell registries. Here we describe some trends in the methodology for establishing hESC lines, discussing the developments in the field. Nevertheless, we describe a much greater heterogeneity of strategies for hESCs derivation than what is used for murine ESC lines, indicating that optimum conditions have not been identified yet, and thus, hESC establishment is still an evolving field of research.
Ana Maria Fraga, Érica Sara Souza de Araújo, Raquel Stabellini, and Naja Vergani have contributed equally to this work.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154–156
Guasch G, Fuchs E (2005) Mice in the world of stem cell biology. Nat Genet 37:1201–1206
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel J, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399–404
Hasegawa K, Pomeroy JE, Pera MF (2010) Current technology for the derivation of pluripotent stem cell lines from human embryos. Cell Stem Cell 6:521–531
Fraga AM, de Araújo ESS, Stabellini R, Vergani N, Pereira LV (2011) A survey of parameters involved in the establishment of new lines of human embryonic stem cell. Stem Cell Rev (in press)
Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227:271–278
Pennings G (2003) New Belgian law on research on human embryos: trust in progress through medical science. J Assist Reprod Genet 20:343–346
Fraga AM, Sukoyan M, Rajan P, Braga DP, Iaconelli A Jr, Franco JG Jr, Borges E Jr, Pereira LV (2010) Establishment of a brazilian line of human embryonic stem cells in defined medium – implications for cell therapy in an ethnically diverse population. Cell Transplant (in press)
Snyder EY, Loring JF (2006) Beyond fraud – stem-cell research continues. N Engl J Med 354:321–324
Laurent LC, Nievergelt CM, Lynch C, Fakunle E, Harness JV, Schmidt U, Galat V, Laslett AL, Otonkoski T, Keirstead HS, Schork A, Park HS, Loring JF (2010) Restricted ethnic diversity in human embryonic stem cell lines. Nat Methods 7:6–7
Mosher JT, Pemberton TJ, Harter K, Wang C, Buzbas EO, Dvorak P, Simón C, Morrison SJ, Rosenberg NA (2010) Lack of population diversity in commonly used human embryonic stem-cell lines. N Engl J Med 362:183–185
Greely HT (2006) Moving human embryonic stem cells from legislature to lab: remaining legal and ethical questions. PLoS Med 3(5):e143
Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R (2006) Human embryonic stem cell lines derived from single blastomeres. Nature 444:481–485
Feki A, Bosman A, Dubuisson JB, Irion O, Dahoun S, Pelte MF, Hovatta O, Jaconi ME (2008) Derivation of the first Swiss human embryonic stem cell line form a single blastomere of an arrested four-cell stage embryo. Swiss Med Wkly 138:540–550
Heins N, Englund MC, Sjöblom C, Dahl U, Tonning A, Bergh C, Lindahl A, Hanson C, Semb H (2004) Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22:367–376
Solter D, Knowles BB (1975) Immunosurgery of mouse blastocyst. Proc Natl Acad Sci USA 72:5099–5102
Martin MJ, Muotri A, Gage F, Varki A (2005) Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11:228–232
Fernandes AM, Meletti T, Guimarães R, Stelling MP, Marinho PAN, Valladão AS, Rehen SK (2010) Worldwide survey of published procedures to culture human embryonic stem cells. Cell Transplant 19:509–523
Horii T, Nagao Y, Tokunaga T, Imai H (2003) Serum-free culture of murine primordial germ cells and embryonic germ cells. Theriogenology 59:1257–1264
Skottman H, Hovatta O (2006) Culture conditions for human embryonic stem cells. Reproduction 132:691–698
Chen AE, Egli D, Niakan K, Deng J, Akutsu H, Yamaki M, Cowan C, Fitz-Gerald C, Zhang K, Melton DA, Eggan K (2009) Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines. Cell Stem Cell 4:103–106
Dahéron L, Opitz SL, Zaehres H, Lensch MW, Andrews PW, Itskovitz-Eldor J, Daley GQ (2004) LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22:770–778
Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW, Jaenisch R (2010) Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA 107:9222–9227
Lengner CJ, Gimelbrant AA, Erwin JA, Cheng AW, Guenther MG, Welstead GG, Alagappan R, Frampton GM, Xu P, Muffat J, Santagata S, Powers D, Barrett CB, Young RA, Lee JT, Jaenisch R, Mitalipova M (2010) Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141:872–883
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Fraga, A.M., de Araújo, É.S.S., Stabellini, R., Vergani, N., Pereira, L.V. (2012). Establishment of New Lines of Human Embryonic Stem Cells: Evolution of the Methodology. In: Turksen, K. (eds) Human Embryonic Stem Cells Handbook. Methods in Molecular Biology, vol 873. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-794-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-61779-794-1_1
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-793-4
Online ISBN: 978-1-61779-794-1
eBook Packages: Springer Protocols